<?xml version="1.0" encoding="UTF-8"?>
<ref id="B26-pharmaceuticals-12-00147">
 <label>26.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Barr</surname>
    <given-names>I.G.</given-names>
   </name>
   <name>
    <surname>Donis</surname>
    <given-names>R.O.</given-names>
   </name>
   <name>
    <surname>Katz</surname>
    <given-names>J.M.</given-names>
   </name>
   <name>
    <surname>McCauley</surname>
    <given-names>J.W.</given-names>
   </name>
   <name>
    <surname>Odagiri</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Trusheim</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Tsai</surname>
    <given-names>T.F.</given-names>
   </name>
   <name>
    <surname>Wentworth</surname>
    <given-names>D.E.</given-names>
   </name>
  </person-group>
  <article-title>Cell culture-derived influenza vaccines in the severe 2017â€“2018 epidemic season: A step towards improved influenza vaccine effectiveness</article-title>
  <source>Npj Vaccines</source>
  <year>2018</year>
  <volume>3</volume>
  <fpage>44</fpage>
  <pub-id pub-id-type="doi">10.1038/s41541-018-0079-z</pub-id>
  <?supplied-pmid 30323955?>
  <pub-id pub-id-type="pmid">30323955</pub-id>
 </element-citation>
</ref>
